95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Meiping Chen
Hui Miao
Hanting Liang
Xiaoan Ke
Hongbo Yang
Fengying Gong
Linjie Wang
Lian Duan
Shi Chen
Hui Pan
Huijuan Zhu*- Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
A Corrigendum on
Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
by Chen M, Miao H, Liang H, Ke X, Yang H, Gong F, Wang L, Duan L, Chen S, Pan H and Zhu H. Front. Endocrinol. (2022) 13:820001. doi: .10.3389/fendo.2022.820001
In the Results, subsection “Comparison of Collagen Gene-Related Short Stature With Other Short Stature Genes and Growth Response to rhGH Treatment”, paragraph 2 as published originally, Table 4 was incorrectly cited. The following sentence “A total of 121 affected individuals diagnosed genetically are shown in Table 3.” should have read “A total of 121 affected individuals diagnosed genetically are shown in Table 4.”
Also, in the Results, subsection “Comparison of Collagen Gene-Related Short Stature With Other Short Stature Genes and Growth Response to rhGH Treatment”, final paragraph, incorrect height Z scores were presented.
The sentences “In ACAN-related short stature, rhGH treatment significantly increased height and the height Z score (from -2.9 ± 1.0 to 0.6 ± 0.7) after 2.8 ± 0.4 years of administration. For NPR2-related short stature, height Z scores were significantly improved from 3.1 ± 0.8 to 2.0 ± 1.0 after 3.8 ± 0.6 years of treatment.” should have read “In ACAN-related short stature, rhGH treatment significantly increased height and the height Z score (from -2.9 ± 1.0 to -2.2 ± 1.1) after 2.8 ± 0.4 years of administration. For NPR2-related short stature, height Z scores were significantly improved from -3.1 ± 0.8 to -2.0 ± 1.0 after 3.8 ± 0.6 years of treatment.”
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: short stature, skeletal abnormalities, collagenopathies, next-generation sequencing, growth hormone treatment
Citation: Chen M, Miao H, Liang H, Ke X, Yang H, Gong F, Wang L, Duan L, Chen S, Pan H and Zhu H (2022) Corrigendum: Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH. Front. Endocrinol. 13:896742. doi: 10.3389/fendo.2022.896742
Received: 15 March 2022; Accepted: 18 March 2022;
Published: 06 April 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Chen, Miao, Liang, Ke, Yang, Gong, Wang, Duan, Chen, Pan and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Huijuan Zhu, c2hlbmd4aW4yMDA0QDE2My5jb20=